Dr. Mohammed Al-Wahsh graduated from the Faculty of Pharmacy at Al-Zaytoonah University of Jordan in 2016 and received his master's degree from the same university in 2018. He received his PhD in 2022 from the University of Heidelberg in Germany in cooperation with the Institute of ISAS in Toxicology and Diseases after being sent from the Faculty of Pharmacy at Al-Zaytoonah University of Jordan. Dr. Mohammed Al-Wahsh created and designed a three-dimensional model of tumors, examined and tested these tumors in a nuclear magnetic resonance machine, and tested their interaction with certain cancer drugs at the Institute of ISAS in Germany.The nuclear magnetic resonance machine also uses a new analytical technique. This technique allows researchers to examine toxicity directly on live three-dimensional cancer cells for the first time and metabolic profiling of human cancer cells of the thymus gland.
Prof. Wafaa Al-Jamal is a graduate of Al-Zaytoonah University of Jordan, Faculty of Pharmacy in 2003. She is an overseas (Jordan) and a UK-registered pharmacist. She completed her PhD in Nanotechnology and Drug Delivery from London School of Pharmacy (now known as UCL School of Pharmacy), following receiving the prestigious Overseas Research Scholarship (ORS) Award from the University of London. Her PhD research project focused on developing novel liposome-based systems for combinatory therapeutic and diagnostic purposes. In 2008, Dr Al-Jamal joined UCL School of Pharmacy as a Research Fellow focusing on live animal imaging and evaluating organ biodistribution of various novel gene and drug delivery vectors. In 2012, she was appointed at The Institute of Pharmaceutical Science, King’s College London as a Senior Research Associate, focusing on evaluating the behaviour and the efficacy of personalised nanomedicines to treat cancer. Dr Al-Jamal joined the University of East Anglia, Norwich, as a Lecturer in Nanomedicine and Drug Delivery (2013-2014), before being awarded a five-year Career Development Fellowship from Prostate Cancer UK, to develop novel nanomedicines targeting metastatic prostate cancer. In August 2017, Dr Al-Jamal joined Queen’s University Belfast School of Pharmacy as a Reader in Nanomedicine and Drug Delivery. In 2023, she was promoted to Professor of Advanced Nanotherapeutics. Prof Al-Jamal is a Visiting Professor at Guizhou Medical School, Guiyang, China. She was the GSK Emerging Scientist Award winner for 2015 for her work in the field of Cancer Nanomedicine. She also received the prestigious international Gro Brundtland Award, Taiwan that recognizes distinguished female scientists in the field of sustainable development.